ライフサイエンスコーパス: mucosa-associated lymphoid tissue

1 n a subpopulation of human memory B cells of mucosa-associated lymphoid tissue.

2 d has been implicated in B cell lymphomas of mucosa-associated lymphoid tissue.

3 /memory lymphocytes to the intestine and the mucosa-associated lymphoid tissue.

4 f gastric adenocarcinoma and lymphoma of the mucosa-associated lymphoid tissue.

5 the spectrum of low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.

6 ts with extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

7 controlling dendritic cell (DC) functions in mucosa-associated lymphoid tissue.

8 s of mammalian mucosal surfaces exhibiting a mucosa-associated lymphoid tissue.

9 ulate the risk of lymphomagenesis in gastric mucosa-associated lymphoid tissue.

10 nfection, most likely through M cells of the mucosa-associated lymphoid tissue.

11 ow trout and that it resembles other teleost mucosa-associated lymphoid tissues.

12 is known about the B cell response to RSV in mucosa-associated lymphoid tissues.

13 eir interaction directs lymphocyte homing to mucosa-associated lymphoid tissues.

14 reased IgD CSR exclusively within B cells of mucosa-associated lymphoid tissues.

15 uded caspase recruitment domain 11 (CARD11), mucosa-associated lymphoid tissue 1 (MALT1) for combined

16 Herein, we found that mucosa-associated lymphoid tissue 1 (MALT1) is involved

17 hoid tissue (LDALT), a first known report of mucosa-associated lymphoid tissue activation at the port

18 ly 50% of patients with gastric lymphomas of mucosa-associated lymphoid tissue, although long-term fo

19 The probable source of persistent virus is mucosa-associated lymphoid tissue, although the molecula

20 Nasal mucosa-associated lymphoid tissue and submandibular lymp

21 NK-22 cells are also found in mouse mucosa-associated lymphoid tissues and appear in the sma

22 he specialized regions where antigens access mucosa-associated lymphoid tissue, are sites where HIV-1

23 Fish lack organized mucosa-associated lymphoid tissues as found in birds and

24 ll lymphomas (DLBCLs), including DLBCLs with mucosa-associated lymphoid tissue (DLBCL[MALT]) and with

25 tered to mimic those normally present within mucosa-associated lymphoid tissues (e.g., Peyer's patche

26 Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (EMZL) invariably deve

27 , five extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue, five anaplastic large

28 of apoptotic cells was also observed in the mucosa-associated lymphoid tissue lining the trachea and

29 uces remission in most patients with gastric mucosa-associated lymphoid tissue lymphoma (GML) that is

30 r risk factor for gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (MALT).

31 Mucosa-associated lymphoid tissue lymphoma (MALToma) is

32 ptake), including 4 patients with coexisting mucosa-associated lymphoid tissue lymphoma (maximal stan

33 lymphoma (n = 6), plasmacytoma (n = 5), and mucosa-associated lymphoid tissue lymphoma (n = 3) were

34 iduals also had an increased risk of stomach mucosa-associated lymphoid tissue lymphoma (SIR, 5.99; 9

35 h the development of both gastric cancer and mucosa-associated lymphoid tissue lymphoma in humans is

36 heilmannii" is associated with gastritis and mucosa-associated lymphoid tissue lymphoma in people.

37 h studies on the diagnosis and management of mucosa-associated lymphoid tissue lymphoma published ear

38 tations of TNFAIP3 have been observed in the mucosa-associated lymphoid tissue lymphoma subtype frequ

39 Brd4, phosphoinositide-3-kinase, annexin A1, mucosa-associated lymphoid tissue lymphoma translocation

40 Constitutive mucosa-associated lymphoid tissue lymphoma translocation

41 , as well as B-cell lymphoma/leukemia 10 and mucosa-associated lymphoid tissue lymphoma translocation

42 tant protein-1-induced protein (MCPIP)-1 and mucosa-associated lymphoid tissue lymphoma translocation

43 part of the CARD-B-cell lymphoma/leukemia 10-mucosa-associated lymphoid tissue lymphoma translocation

44 rotein 3]-BCL-10 [B-cell lymphoma 10]-MALT1 [mucosa-associated lymphoid tissue lymphoma translocation

45 c proteins associated with B-cell lymphomas, mucosa-associated lymphoid tissue lymphoma translocation

46 ablish an important T cell-intrinsic role of mucosa-associated lymphoid tissue lymphoma translocation

47 plex with B-cell CLL/lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue lymphoma translocation

48 ated with B-cell CLL/lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue lymphoma translocation

49 nic lymphocytic leukemia/lymphoma 10 (BCL10)-mucosa-associated lymphoid tissue lymphoma translocation

50 composed of B cell CLL/lymphoma 10 (BCL10), mucosa-associated lymphoid tissue lymphoma translocation

51 The mucosa-associated lymphoid tissue lymphoma translocation

52 ase (MAGUK) protein 1/B-cell CLL-lymphoma 10/mucosa-associated lymphoid tissue lymphoma translocation

53 Among the 50 patients, 32 (64%) had mucosa-associated lymphoid tissue lymphoma, 12 (24%) had

54 pregnancy or nursing, malignancy or gastric mucosa-associated lymphoid tissue lymphoma, allergy or c

55 ical factor in peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and gastric

56 , including gastric and duodenal ulceration, mucosa-associated lymphoid tissue lymphoma, and gastric

57 bserved in diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue lymphoma, being associ

58 ts of distinct chromosomal translocations in mucosa-associated lymphoid tissue lymphoma, cooperate in

59 able outcome; and in patients with low grade mucosa-associated lymphoid tissue lymphoma, eradication

60 Among cases of conjunctival mucosa-associated lymphoid tissue lymphoma, human herpes

61 of diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue lymphoma, lymphomas re

62 ymphoma (MCL), marginal zone lymphoma (MZL), mucosa-associated lymphoid tissue lymphoma, lymphoplasma

63 ents with newly diagnosed, untreated stage I mucosa-associated lymphoid tissue lymphoma, the 2-year l

64 In early gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma, the best ava

65 tudied, gastrointestinal lymphoma is gastric mucosa-associated lymphoid tissue lymphoma, which is a p

66 can cause the development of gastric B cell mucosa-associated lymphoid tissue lymphoma, yet little i

67 otrimers with B-cell lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue lymphoma-translocation

68 ion studies were performed with T cells from mucosa-associated lymphoid tissue lymphoma-translocation

69 (P < .0001); these follicles had features of mucosa-associated lymphoid tissue lymphoma.

70 c ulcer disease, gastric cancer, and gastric mucosa-associated lymphoid tissue lymphoma.

71 ic gastritis, gastric carcinoma, and gastric mucosa-associated lymphoid tissue lymphoma.

72 ing peptic ulcer, gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma.

73 results included 3 additional patients with mucosa-associated lymphoid tissue lymphoma.

74 as even higher (77%) among pSS patients with mucosa-associated lymphoid tissue lymphoma.

75 o consensus on standard initial treatment of mucosa-associated lymphoid tissue lymphoma.

76 disease, gastric adenocarcinoma, or gastric mucosa-associated lymphoid tissue lymphoma.

77 association with gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma.

78 er DLBCLs and never in Burkitt's lymphoma or mucosa-associated lymphoid tissue lymphoma.

79 pylori eradication in patients with gastric mucosa-associated lymphoid tissue lymphoma.

80 treatment planning in patients with gastric mucosa-associated lymphoid tissue lymphoma.

81 c ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma.

82 nsistent with their potential to evolve into mucosa-associated lymphoid tissue lymphoma.

83 onship to gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue lymphoma.(2) In the la

84 lorambucil demonstrated superior efficacy in mucosa-associated lymphoid tissue lymphoma; however, imp

85 3) Extranodal mucosa associated lymphoid tissue lymphomas are easily c

86 lymphomas (2.3%) were the most frequent, and mucosa-associated lymphoid tissue lymphomas (5.8%).

87 This is important as early-stage gastric mucosa-associated lymphoid tissue lymphomas can be manag

88 Further, the development of ocular adnexal mucosa-associated lymphoid tissue lymphomas has been ass

89 trasound, in the diagnosis and management of mucosa-associated lymphoid tissue lymphomas of the stoma

90 understanding of the genetic alterations in mucosa-associated lymphoid tissue lymphomas, including v

91 urkitt's lymphoma, but was observed in 9% of mucosa-associated lymphoid tissue lymphomas.

92 gastric ulcers, gastric adenocarcinomas, and mucosa-associated lymphoid tissue lymphomas.

93 esized that direct intranodal vaccination of mucosa associated lymphoid tissue (MALT) such as the rea

94 Salivary gland mucosa associated lymphoid tissue (MALT) type lymphomas

95 Lymphomas arising in mucosa-associated lymphoid tissue (MALT) are indolent B-

96 l marginal zone (MZ) B-cell lymphomas of the mucosa-associated lymphoid tissue (MALT) arise from lymp

97 Marginal zone mucosa-associated lymphoid tissue (MALT) B-cell lymphoma

98 ow-grade, small lymphocytic lymphomas of the mucosa-associated lymphoid tissue (MALT) have recently b

99 yphlocolitis, associated epithelial defects, mucosa-associated lymphoid tissue (MALT) hyperplasia, an

100 Gastric lymphoma of mucosa-associated lymphoid tissue (MALT) is related to H

101 59 = 42%) (germinal center cell origin) and mucosa-associated lymphoid tissue (MALT) lymphoma (19 of

102 ice has been described as a model of gastric mucosa-associated lymphoid tissue (MALT) lymphoma (GML).

103 ression profiling (GEP) of primary pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma (n = 3

104 While primary ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma (POAML

105 ulture who previously received rituximab for mucosa-associated lymphoid tissue (MALT) lymphoma and st

106 The tendency for gastric mucosa-associated lymphoid tissue (MALT) lymphoma cells

107 Posttreatment evaluation of gastric mucosa-associated lymphoid tissue (MALT) lymphoma curren

108 Since the first description of mucosa-associated lymphoid tissue (MALT) lymphoma in 198

109 jogren's syndrome (SS) developed a low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the

110 reated by the recurrent t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma induce

111 The development of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is dep

112 Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is ind

113 Mucosa-associated lymphoid tissue (MALT) lymphoma is the

114 Mucosa-associated lymphoid tissue (MALT) lymphoma is the

115 Gastric lymphoma resembling gastric mucosa-associated lymphoid tissue (MALT) lymphoma linked

116 Mucosa-associated lymphoid tissue (MALT) lymphoma of the

117 stopathology and immunohistochemistry showed mucosa-associated lymphoid tissue (MALT) lymphoma with i

118 as chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma, and g

119 ude active or inactive peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma, as we

120 he standard of care in patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma, much

121 avourable prognosis of patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma, treat

122 ved in the t(1;14)(p22;q32) translocation of mucosa-associated lymphoid tissue (MALT) lymphoma.

123 is directly involved in t(1;14)(p22;q32) of mucosa-associated lymphoid tissue (MALT) lymphoma.

124 which is the most frequent translocation in mucosa-associated lymphoid tissue (MALT) lymphoma.

125 11;18)(q21;q21) chromosomal translocation in mucosa-associated lymphoid tissue (MALT) lymphoma.

126 ns involving the MALT1 gene are hallmarks of mucosa-associated lymphoid tissue (MALT) lymphoma.

127 ion resulted in the best OS in patients with mucosa-associated lymphoid tissue (MALT) lymphomas (HR =

128 The pathogenesis of mucosa-associated lymphoid tissue (MALT) lymphomas is as

129 Mucosa-associated lymphoid tissue (MALT) lymphomas most

130 phoma specimens, as follows: 8 of 120 (6.7%) mucosa-associated lymphoid tissue (MALT) lymphomas, 4 of

131 ning protein involved in the etiology of the mucosa-associated lymphoid tissue (MALT) lymphomas, has

132 idy are recurrent chromosomal aberrations in mucosa-associated lymphoid tissue (MALT) lymphomas.

133 munoglobulin heavy chain (IgH) locus in some mucosa-associated lymphoid tissue (MALT) lymphomas.

134 Mucosa-associated lymphoid tissue (MALT) may accumulate

135 developments concerning gastric lymphomas of mucosa-associated lymphoid tissue (MALT) origin, ranging

136 Low-grade lesions nearly always arise from mucosa-associated lymphoid tissue (MALT) secondary to ch

137 central player in immune surveillance in the mucosa-associated lymphoid tissue (MALT) such as those i

138 utes can allow antigens to interact with the mucosa-associated lymphoid tissue (MALT) to induce both

139 nodal marginal zone B-cell lymphoma (MZL) of mucosa-associated lymphoid tissue (MALT) type is listed

140 Salivary gland mucosa-associated lymphoid tissue (MALT) type lymphomas

141 nexal lymphoma, is marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) type.

142 a case of primary gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) with a secondar

143 ncurrent gastric and intestinal lymphomas of mucosa-associated lymphoid tissue (MALT), the clonal rel

144 -cell lymphomas (DLBCLs) without features of mucosa-associated lymphoid tissue (MALT), the pure (de n

145 vestigation revealed that she had an orbital mucosa-associated lymphoid tissue (MALT)-type B cell lym

146 Although it is well established that mucosa-associated lymphoid tissue (MALT)-type lymphomas

147 d expression of a number of genes within the mucosa-associated lymphoid tissue (MALT).

148 ith extranodal marginal-zone lymphoma of the mucosa-associated lymphoid tissue (MALT).

149 ed were extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT).

150 ces for extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT).

151 eligible patients (339 with WM, 37 with non-mucosa-associated lymphoid tissue marginal zone lymphoma

152 spores, phagocytosis of spores in the nasal mucosa-associated lymphoid tissue (NALT) and lungs by ma

153 the cervical lymph nodes (CLN) and the nasal mucosa-associated lymphoid tissue (NALT) and tested for

154 ections have two portals of entry, the nasal mucosa-associated lymphoid tissue (NALT) and the lumen o

155 eported that GAS preferentially target nasal mucosa-associated lymphoid tissue (NALT) in mice, a tiss

156 g of iFT from the nasal passage to the nasal mucosa-associated lymphoid tissue (NALT).

157 g inoculation, but not in the adjacent nasal mucosa-associated lymphoid tissue (NALT).

158 lar lymphoma, diffuse large B-cell lymphoma, mucosa-associated lymphoid tissue non-Hodgkin lymphoma,

159 calization, the chief immunoglobulins of all mucosa-associated lymphoid tissue operate under the guid

160 l lymphoma, angiotropic large cell lymphoma, mucosa-associated lymphoid tissue, primary pulmonary T-c

161 omains of c-IAP2 with the paracaspase/MALT1 (mucosa-associated lymphoid tissue) protein, a critical m

162 nversion (RT-QuIC) assay by using recto-anal mucosa-associated lymphoid tissue (RAMALT) biopsy specim

163 ced conversion (RT-QuIC) assay of recto-anal mucosa-associated lymphoid tissue (RAMALT) biopsy specim

164 The examination of rectoanal mucosa-associated lymphoid tissue (RAMALT) biopsy specim

165 Functional analysis of the gastrointestinal mucosa-associated lymphoid tissue revealed increased sig

166 ization of a human NK cell subset located in mucosa-associated lymphoid tissues, such as tonsils and

167 icular-associated epithelium (FAE) overlying mucosa-associated lymphoid tissues, their density increa

168 Gastric B-cell lymphoma of mucosa-associated lymphoid tissue type is closely linked

169 hocyte responses, is aberrantly expressed in mucosa-associated lymphoid tissue-type marginal zone (MZ